admin.veranex

1 min read

Veranex’s Model Assesses EXENT® GAM Assay* Savings in Myeloma Patient Monitoring

The investigational model considered the use of the EXENT® GAM Assay from the Binding Site, part of Thermo Fisher Scientific. This is a mass spectrometry method that may replace current immunofixation testing and may inform the timing of bone...

Read More